C
Constellation Pharmaceuticals
Biotech & Life Sciences · Cambridge, United States · Founded 2008 · IPO 2018 Unicorn
Global footprint
Where Constellation Pharmaceuticals has talent and traffic
Patent intelligence
$116M patent portfolio · 68 active families
Where Constellation Pharmaceuticals concentrates vs peers
Each axis is a top-10 topic across Constellation Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Constellation Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Constellation Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Constellation Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.